L-Histidine decarboxylase (HDC) catalyzes the formation of histamine from L-histidine, and in hematopoietic cell lineages the gene is expressed only in mast cells and basophils. We attempted here to discover how HDC gene expression is restricted in these cells. In the cultured cell lines tested, only the mast cells and basophils strongly transcribed the HDC gene. However, in transient transfection analysis, the reporter constructs with the HDC promoter were active not only in expressing cells but also in nonexpressing cells. Detailed analyses of the HDC promoter region revealed that the GC box is essential for transactivation. Also, the promoter region of the HDC gene proved to be sensitive to DNase I and restriction endonucleases exclusively in HDC-expressing cells, suggesting that the promoter region is readily accessible to trans-acting factor(s). Furthermore, the promoter region in HDC-expressing cell lines was found to be selectively unmethylated. The correlation between HDC expression and hypomethylation was also found in primary human mast cells. Methylation of the HDC promoter in vitro reduced the luciferase reporter activity in transient expression analysis, suggesting that methylation of the promoter region is functionally important for HDC gene expression. These results imply that alteration of DNA methylation is one of the mechanisms regulating cell-specific expression of the HDC gene.
L-Histidine decarboxylase (HDC) catalyzes the formation of histamine from L-histidine, and in hematopoietic cell lineages the gene is expressed only in mast cells and basophils. We attempted here to discover how HDC gene expression is restricted in these cells. In the cultured cell lines tested, only the mast cells and basophils strongly transcribed the HDC gene. However, in transient transfection analysis, the reporter constructs with the HDC promoter were active not only in expressing cells but also in nonexpressing cells. Detailed analyses of the HDC promoter region revealed that the GC box is essential for transactivation. Also, the promoter region of the HDC gene proved to be sensitive to DNase I and restriction endonucleases exclusively in HDC-expressing cells, suggesting that the promoter region is readily accessible to trans-acting factor(s). Furthermore, the promoter region in HDC-expressing cell lines was found to be selectively unmethylated. The correlation between HDC expression and hypomethylation was also found in primary human mast cells. Methylation of the HDC promoter in vitro reduced the luciferase reporter activity in transient expression analysis, suggesting that methylation of the promoter region is functionally important for HDC gene expression. These results imply that alteration of DNA methylation is one of the mechanisms regulating cell-specific expression of the HDC gene.
L-Histidine decarboxylase (HDC 1 ; EC 4.1.1.22) catalyzes the formation of histamine, a bioactive amine known to play various roles in physiological and pathological conditions, such as smooth muscle contraction, gastric acid secretion, cell growth, neurotransmission, and inflammation (1) . The expression of HDC mRNA is detected only in a limited number of tissues and cells, showing a good correlation with the distribution of histamine-mediated functions (2) . We earlier cloned the human HDC gene, analyzing its structure and sequencing entirety, including the 5Ј-flanking region (3) . In hematopoietic lineages, the human HDC gene is expressed in mast cells and basophils, and we have been interested in the mechanism underlying this cell specificity.
Mast cells and basophils are responsible for many pathologic conditions such as systemic anaphylaxis, cutaneous allergic reactions, bronchial asthma, and parasitic infections (4) . It is known that mast cells leave the bone marrow as progenitors and complete their differentiation in peripheral tissues, while basophils complete their differentiation in the bone marrow (4) . Human mast cells can be obtained in vitro by long term culture of CD34-positive cells with stem cell factor (5) . But little is known about the molecular mechanisms underlying the differentiation of mast cells. One of the approaches to this problem is to elucidate how the expression of mast cell-specific genes are regulated. The presence of several lineage-specific transcription factors is reported in mast cells. For example, cell-specific expression of the mast cell-carboxypeptidase A gene is regulated through GATA site (6) . Transcription factors GATA-1, GATA-2, and PU.1 play a critical role in mast cell-specific expression of interleukin-4 through binding to an enhancer in the second intron (7, 8) . We reported that the transcription factor NF-E2 transactivated the mouse HDC gene (9) . It is well known, however, that trans-acting factors are not the only regulators of cell-specific transcription. For example, the CpG methylation or packed chromatin structure exerts negative effects on gene expression and also must be considered to understand the precise mechanisms of specific gene transcription.
We show here that cell-specific expression of HDC mRNA is regulated at the transcriptional level. It is revealed that a region including the GC box sequence in the promoter is essential for transactivation and that Sp1 binds to this GC box. However, lines of evidence that even cell lines that do not transcribe the HDC gene show some transactivation and that there is little difference in binding of nuclear extracts to the GC box between HDC-expressing and -nonexpressing cell lines point to the presence of an additional regulatory mechanism(s). In this study, we observed that the promoter region in HDCexpressing cell lines is more sensitive to nucleases and has unmethylated CpG sites around the transcription initiation site. Moreover, in vitro methylation of reporter plasmids was shown to have inhibitory effects on the HDC gene promoter. These results indicate that chromosomal configuration and methylation of the HDC gene would be critical for the cellspecific transcription of this gene.
with 10% fetal bovine serum, 100 IU/ml penicillin, and 100 g/ml streptomycin. To prepare primary human mast cells, umbilical cord blood samples were obtained from normal full-term deliveries according to the hospital's legal guidelines (National Children's Hospital, Tokyo, Japan). Mononuclear cells were separated by density gradient centrifugation using lymphocyte separation medium (Organon Teknika Corp., Durham, NC). CD34-positive cells were isolated from mononuclear cells using a magnetic separation column according to the manufacturer's instruction (Miltenyi Biotec, Bergisch Gladbach, Germany). The cells were cultured in media I (IBL, Gunma, Japan) containing 5% fetal bovine serum, human recombinant stem cell factor (Kirin Brewery, Maebashi, Japan) at 100 ng/ml and interleukin-6 (Kirin Brewery) at 50 ng/ml for 20 weeks (5). Genomic DNA was isolated by digesting cells with proteinase K in the presence of EDTA and SDS followed by phenol extraction (13) . Total cellular RNA was isolated by the acid guanidinium thiocyanate/phenol/chloroform procedure (14) .
RNA and DNA Blot Hybridization Analyses-HDC mRNA was analyzed by RNA blot hybridization. Twenty-g aliquots of total cellular RNA were electrophoresed in 1% agarose gels under denaturing conditions, transferred to a nylon membrane (Hybond N ϩ , Amersham Pharmacia Biotech), and hybridized with [␣-
32 P]dCTP-labeled cDNA probes at 42°C overnight in hybridization buffer comprising 50% formamide, 5ϫ SSPE, 5ϫ Denhardt's solution, 0.5% SDS, and 200 g/ml salmon sperm DNA. The blots were washed in 2ϫ SSPE, 0.1% SDS; 1 ϫ SSPE, 0.1% SDS; and then 0.1ϫ SSPE, 0.1% SDS at 42°C. DNA blots were hybridized at 65°C overnight in hybridization buffer comprising 5ϫ SSPE, 5ϫ Denhardt's solution, 0.5% SDS, and 20 g/ml salmon sperm DNA. The blots were washed at 65°C in the same buffers as used for RNA blots. The human HDC cDNA probe used was a 1.8-kb PvuIIPvuII (positions 265-2063) restriction fragment from the human HDC cDNA clone, pTN-2 (15). The human ␤-actin probe was a 0.9-kb ScaISmaI (positions 121-1048) restriction fragment from a human ␤-actin cDNA clone (provided by Dr. T. Yamamoto at the Tohoku University Gene Research Center). The HDC probes for genomic Southern analysis were 409-bp PstI-PstI (positions Ϫ612 to Ϫ203) (probe 1 in Fig. 4 ) and 387-bp PstI-PstI (positions Ϫ203 to ϩ184) restriction fragments (probe 2 in Fig. 5 ) and the 238-bp PCR product (probe 3 in Fig. 5 ) amplified with two primers: Pr.1iDS1Eco (5Ј-CCTGATTTCTCTATGTCACT-TCTAG-3Ј (ϩ2298 to ϩ2322)) and Pr.2iUS1Eco (5Ј-CCTGAATTCCA-GAACTGCCCTTG-3Ј (ϩ2535 to ϩ2513)). These fragments were labeled with [␣-32 P]dCTP by random priming (16) . Nuclear Run-on Assay-The nuclear run-on transcription assay was performed basically as described previously (17) (18) (19) . About 2 x 10 7 nuclei were isolated and incubated with [␣-32 P]UTP and unlabeled ATP, CTP, and GTP. The radiolabeled nascent RNA transcripts were treated with 20 units/ml of DNase I at 30°C for 10 min and 1 mg/ml of proteinase K at 42°C for 30 min. RNA was then isolated by the acid guanidinium thiocyanate/phenol/chloroform procedure (14) . Unincorporated [␣-32 P]UTP was removed by two rounds of ammonium acetate/ ethanol precipitation. To prepare cDNA blots, pBluescript KS(ϩ) inserted with human HDC cDNA (positions 236 -2060) or human ␤-actin cDNA (full-length) or without any insert was linearized, alkaline-denatured, and slot-blotted to Hybond N ϩ . Hybridization and washing were performed as described previously (18) . The signal intensity was quantified using a MacBAS bioimaging analyzer (Fuji Film, Tokyo, Japan).
Plasmid Construction-A BamHI/HindIII restriction fragment containing the Ϫ5947 to ϩ97 region just upstream of the first codon of human HDC gene was isolated from pUCHDC(Ϫ5.8k) (kindly provided by Prof. A. Ichikawa, Kyoto University), inserted between BglII and HindIII sites in the 5Ј multiple cloning site (MCS) of the pGL2 basic vector (Promega) to construct pGLϪ5947. To construct pGLϪ4687 and pGLϪ2435, SmaI (MCS)/BglII (Ϫ4687) and SmaI (MCS)/NdeI (Ϫ2435) fragments, respectively, were removed from pGLϪ5947, treated with T4 DNA polymerase to make blunt ends, and self-ligated. pGLϪ278 was constructed from pGLϪ5947 by removing the SacI (MCS)/SacI (Ϫ278) fragment for self-ligation. PCR products amplified with Pr.-1 (5Ј-TGGCTCTCTTGACCAGTCAA-3Ј (Ϫ155 to Ϫ135))/GL primer 2 (Promega) and Pr.-0.5 (5Ј-GGAGCTAAGGTCAAAGAAAG-3Ј (Ϫ53 to Ϫ33))/GL primer 2 using pGLϪ5947 as a template were digested with HindIII, and larger fragments were isolated and cloned into SmaI and HindIII sites of the pGL2 basic vector to produce pGLϪ153 and pGLϪ52, respectively. Because pGLϪ153 does not contain suitable restriction sites for a deletion reaction with exonuclease III, the HindIII-digested PCR fragment used to produce pGLϪ153 was cloned into SmaI and HindIII sites of pBluescript KS(ϩ) to produce pBSϪ153. The BamHI (MCS)/HindIII (MCS) restriction fragment from pBSϪ153 was recloned into BglII and HindIII sites of pGL basic vector to produce pGLBHϪ153. Then pGLBHϪ153 linearized with SacI and XhoI was treated with exonuclease III and mung bean nuclease to make unidirectional deletions and self-ligated to produce pGLϪ123, pGLϪ100, pGLϪ84, and pGLϪ64. Constructs pGLϪ153 GC mut and pGLϪ123 GC mut were generated using the Transformer site-directed mutagenesis kit (CLONTECH) according to the manufacturer's instruction using Pr.Sp1Smut (5Ј-GGACTTTGAAGaatacAGCTAAGGTCAAAG-3Ј (Ϫ67 to Ϫ38; lowercase letters indicate mutations)) as a mutagenic primer. Constructs produced using PCR products were sequenced by dideoxy chain termination method (20) to exclude plasmids with PCR mutation(s).
Transient Expression Analysis-DNA transfection was carried out by the electroporation method (21) . Cells were harvested, washed, and resuspended in PBS at a density of 10 7 cells/ml. A mixture of 320 l of cell suspension and 30 l of DNA solution was incubated in 4-mm-wide cuvettes (Bio-Rad) on ice for 10 min before electroporation. The DNA solutions contained 5 pmol of reporter plasmid, 50 g of pBluescript KS(ϩ) as carrier, and 10 g (for HMC-1 and HeLa) or 2 g (for K562) of pENL ␤-galactosidase expression vector as an internal control per cuvette. Cell suspensions were exposed to an electric pulse of 360 V/960 microfarads (for HeLa), 320 V/960 microfarads (for K562) or 380V/960 microfarads (for HMC-1), provided by a Gene Pulser electroporation device (Bio-Rad). After electroporation, the cuvettes were incubated on ice for 10 min again, and the transfected cells were cultured with 6 ml of medium for 48 h at 37°C under 5% of CO 2 until harvesting. Preparation of cell lysates and luciferase assays was carried out using a Luciferase Assay Kit (Toyo-Inki, Tokyo, Japan). ␤-Galactosidase activities in cell lysates were assayed as described earlier (13) . The luciferase activity was standardized by the ␤-galactosidase activity and was expressed as a relative value to that obtained with the pGL2 basic.
Electrophoretic Mobility Shift Assay (EMSA)-Nuclear extracts were prepared from four cell lines by hypotonic lysis followed by high salt extraction of nuclei as described previously (22) . Double-stranded oligonucleotide DNAs were end-labeled with [␥-
32 P]ATP in the presence of T4 DNA polynucleotide kinase. Five g of nuclear extracts were incubated with 10 4 cpm of the labeled probe at room temperature for 30 min in 22 l of the reaction mixture comprising 25 mM HEPES (pH 7.9), 0.5 mM EDTA (pH 8.0), 50 mM KCl, 10% glycerol, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 2 g of poly(dI-dC), and electrophoresed in 4% polyacrylamide gels at 4°C in 50 mM Tris-HCl, 400 mM glycine, and 2 mM EDTA (pH 8.5). Dried gels were subjected to autoradiography. Synthetic oligonucleotides were added to the reaction mixtures as competitors at a 100-fold molar excess over the input probe concentration. For the supershift analysis, 1 g of anti-Sp1 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was added to the reaction mixture.
Nuclease Sensitivity Assays-Nuclei were isolated as described previously with minor modifications (23) . About 3 ϫ 10 8 cells were harvested, washed in PBS, and resuspended in ice-cold nuclear isolation buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 15 mM Tris-HCl (pH 7.4), 0.1 mM EGTA (pH 7.8), 0.5 mM dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride) containing 0.3 M sucrose at a concentration of 10 7 cells/ml. Cells were lysed by adding Nonidet P-40 (0.5% final concentration) and kept for 5 min on ice. This solution was layered onto the same volume of sucrose solution (1.5 M in nuclear isolation buffer) and centrifuged at 1,000 ϫ g for 10 min at 4°C. The precipitated nuclei were resuspended in glycerol storage buffer (40% glycerol and 0.3 M sucrose in nuclear isolation buffer without phenylmethylsulfonyl fluoride), frozen after aliquoting, and stored at Ϫ70°C until use. Aliquots of nuclei (4 A 260 units in 400 l) were treated with serial 2-fold increasing concentrations of DNase I (28 -448 units/ml) at 37°C for 10 min or with ApaI (200 units/ml) at 37°C for 60 min. The reaction was stopped by the addition of SDS and EDTA to final concentrations of 0.5% and 10 mM, respectively, and followed by digestion at 55°C overnight with proteinase K at a final concentration of 400 g/ml. The reaction mixtures were then extracted with phenol and phenol/chloroform, ethanol precipitation, and treated with 100 g/ml RNase A for 30 min at 37°C. The same extraction and precipitation protocol was then repeated, and these samples were electrophoresed, blotted, and hybridized as stated under "RNA and DNA Blot Hybridization Analysis."
Sodium Bisulfite Genomic Sequencing-Bisulfite genomic sequencing was performed basically as described previously (24 -26) . Ten-g aliquots of EcoRI-digested genomic DNA from cell lines were denatured in 0.3 M of NaOH at 37°C for 15 min in a total volume of 50 l. Next, sulfonation and hydrolytic deamination reactions were carried out by adding 450 l of 2.5 M sodium metabisulfite (Na 2 S 2 O 5 )/10 mM hydroquinone solution (pH 5.0) to the digested genomic DNA and incubating at 50°C for 4 h in the dark. DNA was purified by absorbing to Glassmilk (Bio101) silica matrix and eluted with TE, according to the manufacturer's protocol. Desulfonation reaction were then performed in 0.3 M of NaOH at 37°C for 15 min, and DNA was precipitated with 3 M ammonium acetate/ethanol and resuspended in 100 l of water. PCR amplification was performed in 100 l of reaction mixture containing 5 l of bisulfite-treated genomic DNA, 0.5 M primers, 200 M dNTPs, 2 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl (pH 8.3), and 2.5 units of ExTaq polymerase (Takara, Shiga, Japan) under the following conditions: 94°C for 30 s, 65°C for 1 min, 72°C for 1 min for 35 cycles. Modified primers used in this experiment were as follows: hHDCa1 (5Ј-TTT-GAATTCAGGGGTAGAAAGAATTGAGGG-3Ј (modified sequences from Ϫ267 to Ϫ238)) and hHDCa2 (5Ј-CCATCATCTCCCTTAAACTCTA-ACTCCTTC-3Ј (ϩ113 to ϩ84)) to amplify the sense strand, with hHDCb1 (5Ј-CCTACAAACTTGAATTCCTAAATACACTAC-3Ј (Ϫ209 to Ϫ180)) and hHDCb2 (5Ј-TTTTATAGATGGATATGTAGGAGGTG-GAAG-3Ј (ϩ85 to ϩ56)) to amplify the antisense strand. Amplified DNA was sequenced directly or after subcloning in Bluescript KS(ϩ) by the cycle sequencing method using an ABI PRISM 377 DNA sequencer (Perkin-Elmer).
Patch Methylation of Reporter Plasmid-The reporter plasmid pGLϪ278 was digested with KpnI and HindIII, and the promoter region was gel-isolated. The promoter region was methylated in vitro with 3 units of SssI methylase (New England Biolabs)/g of DNA in the presence of 160 M S-adenosylmethionine at 37°C for 3 h. For the unmethylated control, the same fragment was incubated in the same condition without SssI methylase. Complete methylation of the fragment was confirmed by HpaII and HhaI restriction enzyme digestion. The pGL basic vector digested with KpnI and HindIII was ligated with an equimolar concentration of methylated or unmethylated promoter fragment at 16°C for 30 min at a DNA concentration of 10 g/ml. The DNA was ethanol-precipitated, and 4 g of ligated DNA was transfected using SuperFect transfection reagent (QIAGEN) according to the manufacturer's protocol.
Reverse Transcriptase-PCR-Five hundred ng of total RNA was primed with random hexamer and reverse-transcribed using Superscript II reverse transcriptase (Life Technologies, Inc.) in a total volume of 10 l. The cDNA pool was then diluted 10-fold. PCR was carried out in a total volume of 20 l containing 5 l of cDNA, 0.2 mM dNTP mixture, 100 mM specific sets of primers, and 0. Nucleotide Sequence Accession Number-The GenBank TM accession number for the human L-histidine decarboxylase genomic sequence is D16583.
RESULTS

HDC mRNA Expression and Transcription in Different Cell
Lines-RNA blot analysis of four human cell lines demonstrated HDC mRNA expression in HMC-1 human mast cells and KU-812-F human basophilic leukemia cells but not in HeLa human cervical cancer cells and K562 human erythroleukemia cells (Fig. 1A) . The amount of HDC mRNA in the HMC-1 cells appeared slightly greater than that in KU-812-F cells. Two HDC mRNA species were observed in HMC-1 cells as in KU-812-F cells, which were supposed to be generated by alternative splicing (15) . In order to ascertain whether mast cell-/basophil-specific expression of HDC mRNA is transcriptionally regulated, we performed a nuclear run-on assay. The signal intensities for the HDC gene in HMC-1 and KU-812-F were 57 and 37%, respectively, of those for the ␤-actin gene (Fig. 1B) . In contrast, HDC signals in HeLa and K562 were as weak as those for control pBluescript KS(ϩ) vector signals. These results suggest that the cell-specific expression of HDC mRNA in mast cells and basophils is dependent on transcription.
Deletion Analysis of the HDC Promoter Region-To locate the cis-acting sequence that regulates HDC gene transcription, a series of 5Ј-deleted promoter fragments, including a 97-bp fragment downstream from the transcription initiation site, were fused to the luciferase gene in the pGLϪ2 basic vector and transfected into HMC-1, K562, and HeLa cell lines. Since the efficiency of transfection into KU-812-F was very low, we did not include this cell line. Construct pGLϪ5947, containing 5947 bp upstream from the transcription initiation site, produced a relative luciferase activity of about 75 in HMC-1 cells (Fig. 2A) . This activity was equivalent to that produced by pGL2 control vector, which possesses the SV40 early promoter and enhancer (data not shown). When the promoter region was deleted to Ϫ4687, the relative luciferase activity was reduced by 40% only in HMC-1, suggesting mast cell-specific positive regulatory elements in this region. The deletion to Ϫ52 decreased the luciferase activity to the basal level in all cell lines. Further analysis was made in order to identify the regulatory elements between Ϫ153 and Ϫ52. The removal of sequences between Ϫ153 and Ϫ123 increased the luciferase activity by 64% in HMC-1, indicating the existence of a negative element in this region. Removal of sequences from Ϫ64 to Ϫ52 abolished the reporter activity, suggesting that the GC box in this region was important for promoter activity. The requirement of the GC box was confirmed by the fact that pGLϪ153 GC mut or pGLϪ123 GC mut containing point mutations in the GC box showed significant loss of reporter activity (Fig. 2B) .
Binding of Sp1 in Nuclear Extracts of Four Cell Lines to the GC Box in HDC Promoter
Region-To examine whether nuclear extracts from different cell lines bind to the GC box in different fashions, we performed electrophoretic mobility shift assays using a synthetic oligonucleotide probe (Fig. 3A) . Two major shift bands were observed for all four cell lines, and this shift was specifically inhibited by the addition of a 100-fold molar excess of the cold oligonucleotide (Fig. 3B) . When the mutated probe was used instead of the wild type probe, these two bands were not observed (Fig. 3C) . Furthermore, the addition of anti-Sp1 antibody resulted in retardation of these bands (Fig. 3D) . Bindings of Sp1 were not affected by methylation of GC box, and there was no difference in binding capacity among four cell lines (Fig. 3E) . These results confirm that Sp1 binds to the GC box, whether it is methylated or not, in all four cell lines and that the complexes are not specific to mast cells or basophils. 
Chromatin Structure of the HDC Gene in HDC-expressing
Mast Cells and Basophils-The sensitivity of the promoter region of the HDC gene to DNase I was compared among the four cell lines. Smaller fragments of about 1.8 -1.9 kb after DNase I digestion were found to hybridize with the probe in the HMC-1 and KU-812-F but not in HeLa and K562 cells (Fig. 4A) . These fragments specific to the two cell lines indicate the presence of DNase I-sensitive sites that map to regions just 5Ј of exon I (Fig. 4C) . The absence of the 1.8 -1.9-kb fragments in HeLa and K562 was not found to be due to ineffectiveness of DNase I digestion, because with a higher DNase I concentration, the 6.3-kb EcoRI-EcoRI fragment signal became weaker in all cell lines. We next used restriction endonuclease ApaI, which recognizes a site (Ϫ18 bp relative to the transcription initiation site) in the promoter region (Fig. 4C, asterisk) . The digestion of nuclei with ApaI again produced a strong 1.9-kb fragment in the HMC-1 and KU-812-F, but not in HeLa and K562 cells (Fig. 4B) . Other ApaI-sensitive sites were also found in the first and second introns in HMC-1 and KU-812-F cells (2.8-, 4.9-, and 5.4-kb fragments; Fig. 4 , B and C), indicating that those sites are also accessible to ApaI. We further identified a cell-specific DraI-sensitive site (Ϫ28 bp relative to the initiation site) in the promoter region (data not shown). The results imply that the promoter region of the HDC gene is accessible to various nucleases in HDC-expressing cells.
Methylation State of the HDC Gene-We analyzed the methylation state of the HDC gene using two different methods. First, we performed genomic DNA blot analysis using MspI and HpaII restriction endonuclease digestion. MspI cleaves all CCGG sequences whether or not they are methylated at the second C, while HpaII cleaves only nonmethylated CCGG sites. Probe 2 (Fig. 5C ) hybridized with 2.0-and 1.0-kb fragments after MspI digestion in all cell lines (Fig. 5A, lanes 1-4) . This result corresponded well to the sites predicted by the nucleotide sequence of human HDC gene (Fig. 5C ). HpaII digestion of genomic DNA produced 1.9-and 2.0-kb fragments in HMC-1 and KU-812-F (Fig. 5A, lanes 7 and 8) . Longer fragments were observed in the HeLa and K562 (Fig. 5A, lanes 5 and 6) . Another blot using probe 3 showed two MspI sites on both sides of the second exon to be unmethylated in HMC-1 and KU-812-F ( Fig. 5B ; note the presence of the 1.7-kb fragments in lanes 5 3 . EMSA using oligonucleotides containing the sequences of the GC box. A, the oligonucleotide sequences used. GC/WT probe corresponds to positions Ϫ66 to Ϫ38 of the human HDC gene containing the wild type GC box (boxed). GC/MUT has a 5-nucleotide mutation (boldface type) in the GC box. Met GC probe has 5-methylcytosine in the GC box instead of cytosine at the indicated residues (CH 3 ). B-D, nuclear extracts from four cell lines (indicated at the top of the panel) were incubated with 32 P-labeled probe and electrophoresed in a 4% polyacrylamide gel. The gel was dried and subjected to autoradiography. Two major complexes are indicated by arrows. B, the EMSA was performed using the GC/WT probe with (ϩ lanes) or without (Ϫ lanes) competitor. C, the GC/WT (W lanes) or GC/Mut (M lanes) probe was used. D and E, nuclear extracts were preincubated with (ϩ lanes) or without (Ϫ lanes) 1 g of anti-Sp1 antibody, and EMSA was performed using GC/WT probe (D) or Met GC probe (E). Supershifted complexes are indicated by arrowheads. and 7). The methylation state analyzed by DNA blotting is shown in Fig. 5C .
Next, we looked into the methylation state of the CpG sites around the transcription initiation site using the sodium bisulfite deamination reaction. There are nine CpG sites in this region, which are numbered for convenience (Fig. 6) . After amplification of the sense strand, the cytosine residues in all CpG sites except CpG 1 were sequenced as thymine in HMC-1 and KU-812-F, indicating that these cytosines were unmethylated in these cells. In contrast, all cytosine residues in CpG sites in HeLa and K562 cells were methylated and sequenced as cytosine. These data indicate that the CpG sites around the transcription initiation site of the HDC gene are unmethylated only in HDC-expressing cell lines.
To examine the in vivo significance of the data obtained by in vitro studies with four cell lines, we checked the HDC expression and the methylation state of primary human mast cells derived from CD34-positive cells. The level of HDC mRNA expression of primary mast cells was similar to that of HMC-1 (Fig. 7A) . A slight expression of HDC was also found in CD34 positive progenitor cells (Fig. 7A) . The methylation state of these cells was quantitatively analyzed by the sodium bisulfite method to find that every CpG in the promoter region was more methylated in CD34-positive cells than in primary mast cells (Fig. 7B) . The difference in methylation was especially remarkable at CpG sites 3-9. These results show that CpG sites in the promoter region of HDC gene are hypomethylated in mast cells not only in vitro but also in vivo.
In Vitro Methylation of CpG Sites around the Transcription Initiation Site Decreases Transcriptional Activity-To assess the functional relevance between the methylation state around the transcription initiation site and the transcriptional activity, the fragment containing HDC promoter methylated with 6), HMC-1 (lanes 3 and 7) and KU-812-F (lanes 4 and 8) were first treated with EcoRI and then with MspI (lanes 1-4) or HpaII (lanes 5-8) . The samples were separated, blotted, and hybridized with probe 2. B, each slot was loaded with 5 g of genomic DNA from HeLa (lanes 1 and 2), K562 (lanes 3 and 4), HMC-1 (lanes 5 and 6) , and KU-812-F (lanes 7 and 8) digested with EcoRI and HpaII (lanes 1, 3, 5,  and 7) or EcoRI and MspI (lanes 2, 4, 6, and 8) . The blot was hybridized with probe 3. C, restriction map of the human HDC gene. Exons I and II are represented by thick vertical lines. MspI/HpaII recognition sites (CCGG) and CpG dinucleotides are also indicated. Closed and open circles represent methylated and unmethylated sites, respectively. Two MspI sites in the first intron just 5Ј of the second exon are too close to be discriminated from each other by Southern blot analysis (*). Therefore, at least one of them could be recognized to be unmethylated from the results in B. The lines at the bottom of C represent the expected size of fragments produced by restriction endonuclease digestion.
SssI methylase was ligated to the luciferase gene and transiently expressed in HeLa and HMC-1 cells. As shown in Fig.  8 , in vitro methylation of the promoter region reduced the reporter activity to about 30 -40% as compared with unmethylated control in both cell lines. The result suggests that the CpG methylation in the promoter region of the HDC gene suppresses transcription and contributes to cell-specific expression.
DISCUSSION
Human L-histidine decarboxylase gene expression in hematopoietic cell lines is mainly restricted to basophilic and mast cell lineages (3) . In this paper, we have shown that the cellspecific expression of human HDC mRNA is transcriptionally regulated and that DNA methylation of the promoter region is involved in this process. We detected positive reporter activities and binding activities to the GC box in HeLa and K562 cells although these cell lines do not transcribe the HDC gene. These observations led us to speculate that the activity of the HDC promoter might be under negative control in HDC-nonexpressing cells. Release from the inhibition may control the level of HDC expression in a cell-specific manner. The negative regulation of gene expression is reported to be associated with several distinct mechanisms, such as DNA methylation (27, 28) , transcriptional silencer (29), and chromatin structure (30). We therefore investigated the role of DNA methylation and found a good correlation between the degree of promoter demethylation and constitutive transcriptional activity. Moreover, we have shown that the HDC gene promoter is sensitive to various nucleases specifically in HDC-expressing cell lines.
In transient expression assays, the GC box in the promoter region seemed to be indispensable for transcriptional activity. Taking into account the Sp1 protein binding to the GC box shown by EMSA, we assume that Sp1 is required for HDC transcription. It is known that in vitro binding of proteins to DNA does not always reflect binding in vivo and that even ubiquitous factors bind to target sequences in vivo in a cellspecific manner (31) . From our finding that the promoter region of the HDC gene was accessible to various nucleases specifically in HMC-1 and KU-812-F, it is plausible that the binding of Sp1 to the GC box is mast cell-/basophil-specific in vivo so that the HDC gene is transcribed only in HDC-expressing cells. Interestingly, the intensity of the hybridized signal in the nuclease digestion experiment was stronger in HMC-1 than that in KU-812-F, and this tendency was the same in the RNA blotting and nuclear run-on analysis. These results indicate that accessibility of the promoter region is directly related to the expression of HDC mRNA.
The human and mouse HDC genes have several features in common with regard to their promoter sequences and transcriptional regulation. First, for instance, they both have a GC box and a TATA-like sequence at about position Ϫ55 and Ϫ20, respectively, and the GC box is also important for the transcription of mouse HDC gene. 2 Second, the distribution of CpG dinucleotides around the transcription initiation site is relatively dense. In the human gene, nine CpG sites are found in a 300-bp stretch of nucleotides, and in the mouse gene six CpG sites are present. Third, the promoter of the mouse gene also shows the cell-specific demethylation, and forced demethyla- FIG. 6 . Summary of methylation analysis around the transcription initiation site using the sodium bisulfite genomic sequencing method. Each strand of sodium bisulfite-converted genomic DNA was separately amplified with an appropriate primer set and directly sequenced with these primers. The HDC gene (from Ϫ1.9 kb to ϩ0.4 kb) and CpG distribution are shown at the top. The region around the transcription initiation site (Ϫ270 to ϩ140) is magnified below. CpG sites in this region were numbered for convenience from 1 to 9 as shown. The angled arrow indicates the transcription initiation site. The GC box contains CpG 4. CpG 6 is located in the CCGG site in the first exon shown in Fig. 5C . The closed and open circles show methylated and unmethylated cytosines, respectively. The methylation state of CpG sites 1 and 9 was determined only for the upper strand, because one of the primers (HDC b1) for the lower strand contains the CpG 1 site, and the other one (HDC b2) was designed to be on the 3Ј side of the CpG 9 site (indicated by asterisks). The methylation state of CpG sites 4 and 5 for the lower strand could not be determined from the sequencing data in HeLa and K562 cells. The upper strand was methylated (indicated by triangles). Following sodium bisulfite conversion, each strand was amplified with primers a1 and a2 (for sense strand) or primers b1 and b2 (for antisense strand) and subcloned in pBluescript. Thirty positive recombinants were isolated from each group and sequenced. The number of methylated cytosines at a specific CpG site was divided by the total number of analyzed clone (n ϭ 30) to yield a methylation percentage. The methylation state at CpG sites 1 and 9 for antisense strand could not be determined for the reason described in the legend to Fig. 6 (ND) . tion with 5-azacytidine induced HDC mRNA in P815 mouse mast cell line. 2 These lines of evidence imply that the transcriptions of both human and mouse HDC genes are regulated via the CpG methylation mechanism.
We have shown that ex vivo methylation around the transcription initiation site (CpG sites 1-9) decreases transcriptional activity of the HDC promoter. The selective methylation of CpG sites 1-9, however, did not inhibit transcriptional activity completely, suggesting that the packed chromatin structure revealed in the nuclease sensitivity assay also contributes to transcriptional suppression in HDC-nonexpressing cell lines. Two chief mechanisms have been proposed for the inhibitory effect of CpG methylation on gene expression. First, sequence-specific bindings of many transcription factors are directly inhibited by CpG methylation of their target sequences (32-34). There are some exceptions, however, like Sp1, which can bind to DNA and activates transcription even when the binding site is CpG-methylated (35) (36) (37) . Taking this into account, a single methylation at CpG 4 in the GC box may not be enough for suppression of transcription of the HDC gene. Rather, methylation of all of the CpG sites around the transcription initiation site may be required. Second, CpG methylation exerts an inhibitory effect on gene expression indirectly through the activity of methylated CpG-binding proteins like MeCP1 or -2 (38 -42). MeCP1 needs several methylated cytosines for binding, while MeCP2 binds to DNA containing single symmetrically methylated CpG doublets (39) . MeCP2 is more abundant than MeCP1 in cells and is more tightly bound to DNA containing methyl-CpG doublets in the nucleus (41) . MeCP2 is expressed ubiquitously in most tissues and permanent cell lines including HeLa and K562 (41) , which were used in our study as HDC-nonexpressing cell lines, and possesses an effective transcriptional repressor domain (42) . Therefore, it is possible that the transcription of the HDC gene is inhibited through binding of MeCPs to CpG sites around the transcription initiation site in HDC-nonexpressing cell lines.
Our observations that CpG sites in the HDC promoter were hypomethylated in HDC-expressing cell lines or primary mast cells derived from CD34-positive cells suggest that demethylation takes place in a cell-specific manner. How does demethylation of HDC promoter occur only in mast cells? There are several lines of evidence that a cis-acting element is involved in the demethylation process (43) (44) (45) (46) (47) . For example, in the mouse immunoglobulin gene, a complex cis-acting element including the intronic -chain transcriptional enhancer and the nearby matrix attachment region is required for demethylation to take place, and a trans-acting factor, NF-B, contributes to this process (43, 44) . In another case, Sp1 elements protect a CpG island in the adenine phosporibosyltransferase gene from de novo methylation, and this protection extends about 100 bp on either side (46, 47) . As in the latter case, because the GC box is located in the middle of the hypomethylated region in HDC gene, this element might be involved in the protection of flanking CpG sites from de novo methylation in HDC-expressing cell lines or differentiating mast cells.
A good correlation between the HDC expression and the hypomethylation of HDC promoter found in primary mast cells and CD34-positive cells strongly suggests that the unmethylated state plays an important role in HDC expression not only in vitro but also in vivo. Interestingly, HDC promoter was not completely methylated in CD34-positive cells. A slight expression of HDC mRNA might result from a part of CD34-positive cells in which HDC promoter is unmethylated. It is possible that CD34-positive cells contain the precursor of the mature mast cells and that these precursor cells selectively proliferate and differentiate into mature mast cells in the presence of stem cell factor.
It has been reported that methylation affects chromatin structure and that demethylation creates DNase I-sensitive and nucleosome-free sites (48, 49) . This is in agreement with our findings that a nuclease-sensitive region around the transcription initiation site coincided with the unmethylated region in the HDC-expressing cell lines. Recently, a linkage between DNA methylation and histone deacetylation by MeCP2 was reported (50) . Deducing from this report, it is probable that the maintenance of CpG methylation leads to the recruitment of histone deacetylase via MeCP2, followed by the formation of inactive chromatin around the transcription initiation site in HDC-nonexpressing cells, so that trans-acting factor(s) cannot get access to the HDC promoter. However, we cannot deny the possibility that the change in chromatin structure of HDC promoter occurs independently of CpG methylation of the HDC gene, because there is supporting evidence using transgenic mice that the bulk chromatin structure of a transgene does not vary with its methylation status (51) .
In a previous report, we demonstrated that some cis-acting elements enhanced HDC expression in a cell-specific manner (52) . The present results provide proof that chromosomal configuration and methylation of the HDC promoter are important for mast cell-and basophil-specific expression and suggest an involvement of the demethylation process in human mast cell differentiation. FIG. 8 . The effect of in vitro methylation on transcriptional activity. The fragment containing HDC promoter (positions Ϫ278 to ϩ97) was in vitro methylated or not methylated with SssI methylase and ligated with luciferase gene. These regionally methylated or unmethylated reporter constructs were transfected into HeLa and HMC-1 cells. Reporter activity of methylated construct is expressed as a percentage of the activity of unmethylated plasmid. Each column represents the averaged value Ϯ S.E. of three independent experiments performed in duplicate.
